Download
document-3.pdf 1,46MB
WeightNameValue
1000 Titel
  • Inflammation, glucose, and vascular cell damage: the role of the pentose phosphate pathway
1000 Autor/in
  1. Peiró, Concepción |
  2. Romacho, Tania |
  3. Azcutia, Verónica |
  4. Villalobos, Laura |
  5. Fernández, Emilio |
  6. Bolaños, Juan P. |
  7. Moncada, Salvador |
  8. Sánchez-Ferrer, Carlos F. |
1000 Erscheinungsjahr 2016
1000 LeibnizOpen
1000 Art der Datei
1000 Publikationstyp
  1. Artikel |
1000 Online veröffentlicht
  • 2016-06-01
1000 Erschienen in
1000 Quellenangabe
  • 15:82
1000 FRL-Sammlung
1000 Copyrightjahr
  • 2016
1000 Lizenz
1000 Verlagsversion
  • https://doi.org/10.1186/s12933-016-0397-2 |
  • https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4888494/ |
1000 Ergänzendes Material
  • https://cardiab.biomedcentral.com/articles/10.1186/s12933-016-0397-2 |
1000 Publikationsstatus
1000 Begutachtungsstatus
1000 Sprache der Publikation
1000 Abstract/Summary
  • BACKGROUND: Hyperglycemia is acknowledged as a pro‑inflammatory condition and a major cause of vascular damage. Nevertheless, we have previously described that high glucose only promotes inflammation in human vascular cells previously primed with pro‑inflammatory stimuli, such as the cytokine interleukin (IL)1β. Here, we aimed to identify the cellular mechanisms by which high glucose exacerbates the vascular inflammation induced by IL1β. METHODS: Cultured human aortic smooth muscle cells (HASMC) and isolated rat mesenteric microvessels were treated with IL1β in medium containing 5.5–22 mmol/L glucose. Glucose uptake and consumption, lactate production, GLUT1 levels, NADPH oxidase activity and inflammatory signalling (nuclear factor‑κB activation and inducible nitric oxide synthase expression) were measured in HASMC, while endothelium‑dependent relaxations to acetylcholine were determined in rat microvessels. Pharmacological inhibition of IL1 receptors, NADPH oxidase and glucose‑6‑phosphate dehydrogenase (G6PD), as well as silencing of G6PD, were also performed. Moreover, the pentose phosphate pathway (PPP) activity and the levels of reduced glutathione were determined. RESULTS: We found that excess glucose uptake in HASMC cultured in 22 mM glucose only occurred following activation with IL1β. However, the simple entry of glucose was not enough to be deleterious since over‑expression of the glucose transporter GLUT1 or increased glucose uptake following inhibition of mitochondrial respiration by sodium azide was not sufficient to trigger inflammatory mechanisms. In fact, besides allowing glucose entry, IL1β activated the PPP, thus permitting some of the excess glucose to be metabolized via this route. This in turn led to an overactivation NADPH oxidase, resulting in increased generation of free radicals and the subsequent downstream pro‑inflammatory signalling. Moreover, in rat mesenteric microvessels high glucose incubation enhanced the endothelial dysfunction induced by IL1β by a mechanism which was abrogated by the inhibition of the PPP. CONCLUSIONS: A pro‑inflammatory stimulus like IL1β transforms excess glucose into a vascular deleterious agent by causing an increase in glucose uptake and its subsequent diversion into the PPP, promoting the pro‑oxidant conditions required for the exacerbation of pro‑oxidant and pro‑inflammatory pathways. We propose that overactivation of the PPP is a crucial mechanism for the vascular damage associated to hyperglycemia.
1000 Sacherschließung
lokal Oxidative stress
lokal Pentose phosphate pathway
lokal Inflammation
lokal High glucose
lokal Vascular cells
1000 Fachgruppe
  1. Biologie |
1000 Fächerklassifikation (DDC)
1000 Liste der Beteiligten
  1. https://frl.publisso.de/adhoc/creator/IFBlaXLDsywgQ29uY2VwY2nDs24=|http://orcid.org/0000-0002-0962-7163|https://frl.publisso.de/adhoc/creator/QXpjdXRpYSwgVmVyw7NuaWNh|https://frl.publisso.de/adhoc/creator/VmlsbGFsb2JvcywgTGF1cmE=|https://frl.publisso.de/adhoc/creator/RmVybsOhbmRleiwgRW1pbGlv|https://frl.publisso.de/adhoc/creator/Qm9sYcOxb3MsIEp1YW4gUC4=|https://frl.publisso.de/adhoc/creator/TW9uY2FkYSwgU2FsdmFkb3I=|https://frl.publisso.de/adhoc/creator/U8OhbmNoZXotRmVycmVyLCBDYXJsb3MgRi4=
1000 Label
1000 Förderer
  1. Plan Nacional de I+ D
  2. Sociedad Española de Farmacología-Almirall
  3. Fundación Eugenio Rodríguez Pascual
  4. ISCIII
  5. Junta de Castilla y León
  6. CONACYT
  7. European Commission
1000 Fördernummer
  1. SAF2014-52762-R
  2. -
  3. -
  4. RETICEF-R12/0043/0021
  5. SA003U13
  6. -
  7. 2012-IEF-328793 ADDIO
1000 Förderprogramm
  1. -
  2. -
  3. -
  4. -
  5. -
  6. -
  7. Marie Curie Intra-European Fellowship
1000 Dateien
1000 Objektart article
1000 Beschrieben durch
1000 @id frl:6408170.rdf
1000 Erstellt am 2018-05-30T11:57:00.699+0200
1000 Erstellt von 218
1000 beschreibt frl:6408170
1000 Bearbeitet von 122
1000 Zuletzt bearbeitet Fri Jan 31 00:10:22 CET 2020
1000 Objekt bearb. Thu Jul 12 10:17:23 CEST 2018
1000 Vgl. frl:6408170
1000 Oai Id
  1. oai:frl.publisso.de:frl:6408170 |
1000 Sichtbarkeit Metadaten public
1000 Sichtbarkeit Daten public
1000 Gegenstand von

View source